ES2578729T3 - Agente terapéutico para enfermedades relacionadas con el hígado - Google Patents
Agente terapéutico para enfermedades relacionadas con el hígado Download PDFInfo
- Publication number
- ES2578729T3 ES2578729T3 ES10812011.4T ES10812011T ES2578729T3 ES 2578729 T3 ES2578729 T3 ES 2578729T3 ES 10812011 T ES10812011 T ES 10812011T ES 2578729 T3 ES2578729 T3 ES 2578729T3
- Authority
- ES
- Spain
- Prior art keywords
- therapeutic agent
- related diseases
- liver related
- liver
- vein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Un agente terapéutico que comprende células progenitoras multilinaje derivadas de tejido adiposo para su uso en el tratamiento de una enfermedad relacionada con el hígado, donde el agente es para administrar a través de la vena porta, a través de una vena, a través de una arteria, o a través de un conducto biliar.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009198166 | 2009-08-28 | ||
JP2009198166 | 2009-08-28 | ||
PCT/JP2010/064623 WO2011024962A1 (ja) | 2009-08-28 | 2010-08-27 | 肝臓関連疾患治療薬 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2578729T3 true ES2578729T3 (es) | 2016-07-29 |
Family
ID=43628060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES10812011.4T Active ES2578729T3 (es) | 2009-08-28 | 2010-08-27 | Agente terapéutico para enfermedades relacionadas con el hígado |
Country Status (5)
Country | Link |
---|---|
US (1) | US8784803B2 (es) |
EP (1) | EP2471542B1 (es) |
JP (1) | JP4965000B2 (es) |
ES (1) | ES2578729T3 (es) |
WO (1) | WO2011024962A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2554176B1 (en) * | 2011-08-04 | 2016-07-27 | ETHIANUM Betriebsgesellschaft mbH & Co. KG | Means for liver regeneration |
US9533013B2 (en) * | 2013-03-13 | 2017-01-03 | University Of North Carolina At Chapel Hill | Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree |
US10537525B2 (en) | 2015-04-14 | 2020-01-21 | Mayo Foundation For Medical Education And Research | Methods and materials for delivering agents to liver tissue |
JP6923137B2 (ja) * | 2018-06-15 | 2021-08-18 | 有限会社大阪空気機械サービス | 組織治癒剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE286118T1 (de) * | 1998-03-13 | 2005-01-15 | Osiris Therapeutics Inc | Anwendungen für humane nicht autologe, mesenchymale stammzellen |
US20030082152A1 (en) * | 1999-03-10 | 2003-05-01 | Hedrick Marc H. | Adipose-derived stem cells and lattices |
US20030161816A1 (en) * | 2001-12-07 | 2003-08-28 | Fraser John K. | Systems and methods for treating patients with processed lipoaspirate cells |
ES2257225B1 (es) * | 2006-02-17 | 2007-03-16 | Grifols, S.A | Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion. |
JP2009535035A (ja) | 2006-04-25 | 2009-10-01 | ボード オブ スーパーバイザーズ オブ ルイジアナ ステイト ユニバーシティ アンド アグリカルチュラル アンド メカニカル カレッジ | 肝臓再生における脂肪細胞由来成体幹細胞 |
PL2047414T3 (pl) | 2006-08-03 | 2014-03-31 | Smart Packaging Solutions Sps | Zabezpieczony dokument, zwłaszcza paszport elektroniczny ze wzmocnionym zabezpieczeniem |
EP2166084A4 (en) * | 2007-06-14 | 2010-06-23 | Found Biomedical Res & Innov | MULTIPOTENTE PRECURSOR CELLS FROM FAT |
JP5338322B2 (ja) | 2008-01-11 | 2013-11-13 | ダイキン工業株式会社 | 空気調和装置の室内ユニット |
-
2010
- 2010-08-27 EP EP10812011.4A patent/EP2471542B1/en active Active
- 2010-08-27 US US13/393,023 patent/US8784803B2/en active Active
- 2010-08-27 JP JP2011528875A patent/JP4965000B2/ja active Active
- 2010-08-27 WO PCT/JP2010/064623 patent/WO2011024962A1/ja active Application Filing
- 2010-08-27 ES ES10812011.4T patent/ES2578729T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
US8784803B2 (en) | 2014-07-22 |
JPWO2011024962A1 (ja) | 2013-01-31 |
EP2471542A1 (en) | 2012-07-04 |
US20120156181A1 (en) | 2012-06-21 |
WO2011024962A1 (ja) | 2011-03-03 |
EP2471542B1 (en) | 2016-04-27 |
EP2471542A4 (en) | 2013-11-20 |
JP4965000B2 (ja) | 2012-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2021000028A1 (en) | Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject | |
SV2011003939A (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
PE20181139A1 (es) | Composiciones y metodos para inhibir la expresion genica de lpa | |
CR11749A (es) | Tratamiento de la disnea asociada con insuficiencia cardiaca aguda con relaxina | |
CL2012002037A1 (es) | Uso de agonista doble del glucagon-glp-1 como agente inotropico en el tratamiento de la cardiopatía o la disfuncion cardiaca | |
UA99152C2 (ru) | Восстановление и регенерация почечной ткани с использованием клеток, полученных с человеческой ткани пупочного канатика | |
ES2422739T3 (es) | Composición para el diagnóstico, prevención o tratamiento de enfermedades relacionadas con células que expresan IL-8 o GRO-, que comprende MSC de UCB | |
NI200800169A (es) | Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor | |
EA201300121A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
EA201100358A1 (ru) | Дабигатран для чрескожной хирургической катетеризации сердца | |
PA8794401A1 (es) | Acidos 6-fenilnicotinicos sustituidos y su uso | |
CL2012001961A1 (es) | Método para tratar una enfermedad o trastorno en que aumentan los niveles de hormonas de estrés y/o disminuyen los niveles de hormonas de andrógenos, en que se administra un compuesto pirrolo-[1,2-c]-imidazol-bencil sustituido; su uso en insuficiencia cardíaca, entre otros; y compuestos pirrolo-[1,2-c]-imidazol-bencil sustituidos. | |
ES2578729T3 (es) | Agente terapéutico para enfermedades relacionadas con el hígado | |
CO6300964A2 (es) | Una composicion farmaceutica que comprende una combinacion de un agente quimioterapeutico y un anticuerpo 3 antiglipicano | |
PE20181332A1 (es) | Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos | |
CL2008002984A1 (es) | Composicion farmaceutica que comprende micofenolato sodico y su uso para el tratamiento y/o prevencion en enfermedades autoinmunes tales como el rechazo de aloinjertos o xenoinjertos de organos, celulas o tejidos y como antiinflamatorio. | |
WO2009004995A1 (ja) | 生理活性物質を定着および発現させる方法 | |
ES2552654T3 (es) | Uso de LCAT para tratar la anemia y la disfunción de los glóbulos rojos | |
BR112014003071A2 (pt) | tratamento de doença vascular periférica com o uso de células derivadas do tecido do cordão umbilical | |
BR112012017994B8 (pt) | composição líquida, uso de uma composição líquida, e, métodos para preparar uma composição líquida e para tratamento de um distúrbio | |
BR112014020271A8 (pt) | Composição farmacêutica e métodos para diminuir a frequência de micção em paciente | |
BR112013000613A2 (pt) | composições secas e dispositivos que contêm tais composições secas | |
RU2012131164A (ru) | (метилсульфонил)этил-бензол-изоиндолиновые производные и их терапевтическое применение | |
ECSP10010464A (es) | Uso de ranolazina para el tratamiento de enfermedades cardiovasculares | |
SG10201804772UA (en) | Method of imaging living tissue |